Androgen deprivation therapy for advanced prostate cancer can cause significant side effects and morbidity. This lecture describes a seminar-based service development which was devised to enable men to understand their treatment and side effects, to suggest lifestyle changes to mitigate long-term effects and to empower men to take an active part in their care. The rationale and implementation of this development are discussed along with its evaluation and benefit to men and their loved ones.

Contact hours available until 10/26/17.

Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation. You will be able to print your CNE certificate at any time after you complete the evaluation.

Planning Committee Disclosures:
• Gina Powley - Astellas/Medivation speaker bureau, Ferring Pharmaceuticals speaker bureau
• Leanne Schimke, MSN, CRNP, CUNP - Consultant: Bayer, Speaker's Bureau: Bayer
• Valre Welch, MSN, CPNP - Holister Continence Care Advisory Board; Speaker for Hollister Incontinence Workshops

Speaker Disclosures:
Louisa Fleure, MSc RN - Consultant: Sanofi, Astellas Jannsen; Grant/Research Support: Astellas, Takeda, Ferring

Commercial Support and Sponsorship:
No commercial support or sponsorship declared.

Accreditation Statement:
Society of Urologic Nurses and Associates is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

SUNA is a provider approved by the California Board of Registered Nursing, provider number, CEP 5556.

Objectives:
1. Recognize the impact of ADT.
2. Apply an approach to educating and empowering men on ADT.

Louisa Fleure MSc, RN

Appearances